ctrl K

Watchlist Price Alert

Cognition Therapeutics In... (CGTX)

NASDAQ: CGTX · Real-Time Price · USD

0.32

-0.01 (-4.05%)

At close: May 15, 2025, 1:10 PM

Cognition Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	252K	235K	93K	98K	81K
Gross Profit	n/a	-252K	-235K	-93K	-98K	-81K
Operating Income	-53.97M	-50.72M	-43.55M	-28.6M	-17.41M	-17.83M
Interest Income	n/a	27K	22.22M	17.45M	10.86M	13.16M
Pretax Income	-33.97M	-25.79M	-21.4M	-11.72M	-7.84M	-4.84M
Net Income	-33.97M	-25.79M	757K	-10.29M	-10.07M	-6.95M
Selling & General & Admin	12.29M	13.53M	13.23M	10.03M	4.52M	3.45M
Research & Development	41.68M	37.2M	30.32M	18.57M	12.89M	14.38M
Other Expenses	n/a	n/a	-22.22M	-17.45M	-10.86M	-13.16M
Operating Expenses	53.97M	50.72M	21.33M	11.15M	6.55M	4.67M
Interest Expense	n/a	n/a	28K	893K	1.75M	1.02M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	50.72M	21.33M	11.15M	6.55M	4.67M
Income Tax Expense	n/a	n/a	-22.15M	-1.43M	2.23M	2.11M
Shares Outstanding (Basic)	39.73M	29.99M	28.99M	22.23M	21.94M	21.94M
Shares Outstanding (Diluted)	39.73M	30.03M	28.99M	22.23M	21.94M	21.94M
EPS (Basic)	-0.86	-0.86	0.03	-0.46	-0.46	-0.32
EPS (Diluted)	-0.86	-0.86	0.03	-0.46	-0.46	-0.32
EBITDA	-33.68M	-25.51M	-21.13M	-13.38M	-5.99M	-3.5M
EBIT	-34M	-25.76M	-21.37M	-10.82M	-6.09M	-3.82M
Depreciation & Amortization	316K	252K	235K	93K	98K	81K